Neurology
News
Watch for buprenorphine ‘spiking’ in urine drug tests
Some patients undergoing treatment for opioid use disorder alter their urine drug test results by adding buprenorphine directly to their urine.
News
Mortality risk in epilepsy: New data
“To our knowledge, this is the only study that has assessed the cause-specific mortality risk among people with epilepsy according to age and...
News
Restless legs a new modifiable risk factor for dementia?
Restless legs syndrome is associated with poor sleep, depression/anxiety, poor diet, microvasculopathy, and hypoxia.
Commentary
Bruce Willis’ frontotemporal dementia is not your grandpa’s dementia
‘We tend to characterize dementia as the erosion of memory, but FTD is more characterized by the loss of control over emotions and other cognitive...
News
Children with ASD less likely to get vision screening
While 59.9% of children without ASD got vision screening in these visits, only 36.5% of children with ASD got the screening. Both screening rates...
News
What’s driving the "world’s fastest-growing brain disease"?
The chemical trichloroethylene (TCE) is associated with as much as a 500% increased risk for Parkinson’s disease (PD), suggests a new review data...
Commentary
Can particles in dairy and beef cause cancer and MS?
Researchers found single-stranded DNA rings that originated in viruses, which they named bovine meat and milk factors, in the intestines of...
Commentary
Clinician violence: Virtual reality to the rescue?
Workplace violence is affecting so many providers in hospital emergency departments but also throughout other parts of the hospital.
News
Once-daily stimulant for ADHD safe, effective at 1 year
The most common Treatment-emergent adverse events during the treatment phase were decreased appetite, upper respiratory tract infection,...
Conference Coverage
Antipsychotic cuts Alzheimer’s-related agitation
Brexpiprazole will become the first drug to be approved for agitation in AD, doctor speculates.